On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...